Even though PI3K pathway activation seems to have a key role in K-Ras-induced carcinogenesis, preclinical data suggest that inhibiting PI3K signaling alone may not be entirely effective against K-Ras mutant cancer cell lines or tumors [31,67]. This evidence concerns the gene PIK3CD and cancer.